NCI Will Help CMS Make “Tough Decisions” On Cancer Drug Coverage
Executive Summary
The Centers for Medicare & Medicaid Services will be working in collaboration with the National Cancer Institute to help make some "tough" decisions about cancer coverage, CMS Administrator Mark McClellan said June 15 at a Manhattan Institute luncheon in New York
You may also be interested in...
CMS Off-Label Cancer Coverage Proposal Questioned By ASCO
CMS' proposal to cover clinical trials evaluating four colorectal cancer drugs in off-label uses is not a wise use of taxpayer dollars, the American Society of Clinical Oncology suggests in comments on the draft policy
CMS Off-Label Cancer Coverage Proposal Questioned By ASCO
CMS' proposal to cover clinical trials evaluating four colorectal cancer drugs in off-label uses is not a wise use of taxpayer dollars, the American Society of Clinical Oncology suggests in comments on the draft policy
CMS Off-Label Coverage Decision For Colorectal Cancer Rx Coming Soon
The Centers for Medicare & Medicaid Services expects to release proposed national coverage determinations on off-label use of colorectal cancer drugs in the "near future," CMS Chief Medical Officer Sean Tunis, MD, said Sept. 30 at a CMS workshop in Baltimore